1
Levy Odile Esther, Hanley Michael R, Jodka Carolyn M, Lewis Diana, Soares Christopher J, Ghosh Soumitra S, D Souza Lawrence, Parkes David G, Mack Christine M, Forood Behrouz Bruce: Hybrid polypeptides with selectable properties. Amylin Pharmaceuticals, Levy Odile Esther, Hanley Michael R, Jodka Carolyn M, Lewis Diana, Soares Christopher J, Ghosh Soumitra S, D Souza Lawrence, Parkes David G, Mack Christine M, Forood Behrouz Bruce, INTELLECTUAL PROPERTY DEPARTMENT, February 22, 2007: WO/2007/022123 (42 worldwide citation)

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel ...


2
Levy Odile Esther, Hanley Michael R, Jodka Carolyn M, Lewis Diana Y, Soares Christopher J, Ghosh Soumitra S, D Souza Lawrence J, Parkes David G, Mack Christine M: Hybrid polypeptides with selectable properties. Amylin Pharmaceuticals, Levy Odile Esther, Hanley Michael R, Jodka Carolyn M, Lewis Diana Y, Soares Christopher J, Ghosh Soumitra S, D Souza Lawrence J, Parkes David G, Mack Christine M, MARSH David R, August 25, 2005: WO/2005/077072 (19 worldwide citation)

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel ...


3

4
Soares Christopher J, Hanley Michael R, Lewis Diana Yvonne, Parkes David Geoffrey, Jodka Carolyn Marie, Prickett Kathryn S, Ghosh Soumitra, Mack Christine Marie, Lin Qing: Amylin family peptides and methods for making and using them. Amylin Pharmaceuticals, MARSH David R, August 10, 2006: WO/2006/083254 (15 worldwide citation)

The present invention relates to novel compounds having a function of a peptide in the amylin family, related nucleic acids, expression constructs, host cells, and processes production of the compounds. The compounds of the invention include one or more amino acid sequence modifications. In addition ...


5

6
LEVY ODILE ESTHER, HANLEY MICHAEL R, JODKA CAROLYN M, LEWIS DIANA, SOARES CHRISTOPHER J, GHOSH SOUMITRA S, D SOUZA LAWRENCE, PARKES DAVID G, MACK CHRISTINE M, FOROOD BEHROUZ BRUCE: Hybrid polypeptides with selectable properties, Hybridpolypeptide mit auswählbaren Eigenschaften, Polypeptides hybrides ayant des propriétés sélectionnables. AMYLIN PHARMACEUTICALS, June 8, 2011: EP2330125-A2 (8 worldwide citation)

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel ...


7
Ghosh Soumitra Shankar, Lewis Diana Y, Janssen Samuel, Srivastava Ved, Liu Que, Jodka Carolyn M, Soares Christopher J, Lin Qing: Composition and methods for treatment of congestive heart failure. Amylin Pharmaceuticals, Ghosh Soumitra Shankar, Lewis Diana Y, Janssen Samuel, Srivastava Ved, Liu Que, Jodka Carolyn M, Soares Christopher J, Lin Qing, BUTLER James E, December 6, 2007: WO/2007/139941 (6 worldwide citation)

Provided herein is the use of GLP-1 molecules or agonists and analogs thereof, and the use of exendin molecules or agonists and analogs thereof, including their derivatives and active fragments, for the prevention or treatment of congestive heart failure. Pharmaceutical compositions for use in the m ...


8
LEVY ODILE ESTHER, HANLEY MICHAEL R, JODKA CAROLYN M, LEWIS DIANA, SOARES CHRISTOPHER J, GHOSH SOUMITRA S, D SOUZA LAWRENCE, PARKES DAVID G, MACK CHRISTINE M, FOROOD BEHROUZ BRUCE: Hybrid polypeptides with selectable properties, Hybridpolypeptide mit auswählbaren Eigenschaften, Polypeptides hybrides ayant des propriétés sélectionnables. AMYLIN PHARMACEUTICALS, June 8, 2011: EP2330124-A2 (5 worldwide citation)

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel ...


9
Ghosh Soumitra S, Alfaro Lopez Josue, D Souza Lawrence J, Levy Odile Esther, Lin Qing, Soares Christopher J: Peptide-peptidase inhibitor conjugates and methods of making and using same. Amylin Pharmaceuticals, Ghosh Soumitra S, Alfaro Lopez Josue, D Souza Lawrence J, Levy Odile Esther, Lin Qing, Soares Christopher J, Amylin Pharmaceuticals, April 2, 2009: WO/2009/042922 (4 worldwide citation)

Peptide-peptidase inhibitor conjugate molecules and methods of manufacture thereof are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but ...


10
Levy Odile Esther, Hanley Michael R, Jodka Carolyn M, Lewis Diana Y, Soares Christopher J, Ghosh Soumitra S, D Souza Lawrence J, Parkes David G, Mack Christine M: Hybrid polypeptides with selectable properties. Amylin Pharmaceuticals, November 8, 2006: EP1718665-A2 (3 worldwide citation)

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel ...